Omega-3 Fatty Acids and Mental Health: Assessment of  Pharmacists’ Knowledge and Educational Needs

Alina Kotchetkov; Magdy Kamel

doi:10.53103/cjess.v5i4.370

Authors

Alina Kotchetkov Barrie North Collegiate Institute, Canada
Magdy Kamel Pure Health Pharmacy, Canada

DOI:

https://doi.org/10.53103/cjess.v5i4.370

Keywords:

Omega-3, Fatty Acid, Pharmacist, Mental Health, Brain Health, Cognitive Health

Abstract

Introduction: There has been a growing interest in Omega-3 fatty acids (FAs) for mental/cognitive health. Cognitive impairment, a global problem affecting millions of people, is frequent among elderly, and it influences the individual’s ability to function independently. Omega-3 FAs are natural health products (NHPs), and pharmacists are the front-line healthcare practitioners who provide counselling to patients. Purpose: To identify the current knowledge status of pharmacists on Omega-3 FA NHPs and their confidence levels in counselling patients on these products via a study done in pharmacies in Ontario, Canada. Methods: To identify areas for improvement we assessed knowledge and understanding of Omega-3 FA NHPs of community and hospital pharmacists via a survey. Results: Seventy-six percent of pharmacists were enquired about Omega-3 FA at least once per month. Pharmacists have good knowledge of Omega-3 chemistry, major components, and differences between Omega-3 and -6 FAs. Sixty-four percent of responders identified brain health as benefits; the other health benefits are less widely recognized. Sixty percent of pharmacists were concerned about the increased risk of bleeding; however, only 6% felt confident in counselling patients on Omega-3 FA NHPs. Previous training on Omega-3 was associated with better knowledge of Omega-3 and had positive impact on pharmacists’ confidence in counselling. Conclusion: There are gaps in pharmacist’s current knowledge on Omega-3 FA health benefits and there is unsatisfactory confidence in providing patient counselling. Thus, there is a need for comprehensive education on Omega-3 FA NHPs in addition to traditional medical, naturopathic, and pharmacy formal education.

Downloads

Download data is not yet available.

References

Alexander, D.D., Bassett J.K., Weed D.L., Barrett E.C., Watson H., & Harris W. (2015). Meta-analysis of long-chain omega-3 polyunsaturated fatty acids (LCω-3PUFA) and prostate cancer. Nutr Cancer, 67(4), 543-554.

Andriambelo, B., Stiffel M., Roke K., & Plourde M. (2023). New perspectives on randomized controlled trials with omega-3 fatty acid supplements and cognition: A scoping review. Ageing Res Rev, 85, 101835.

Begtrup, K.M., Krag A.E., & Hvas A.M. (2017). No impact of fish oil supplements on bleeding risk: a systematic review. Dan Med J, 64(5), A5366.

Beutler, J. (2000). Life in the balance. The critical need for Omega-3 supplementation. Natural Medicine Online, Jul,1-8.

Boston, P.F., Bennett A., Horrobin D.F., & Bennett C.N. (2004). Ethyl-EPA in Alzheimer's disease--a pilot study. Prostaglandins Leukot Essent Fatty Acids, 71(5), 341-346.

Bradbury, J. (2011). Docosahexaenoic acid (DHA): an ancient nutrient for the modern human brain. Nutrients, 3(5), 529-554.

Clark, C.M., Monahan K.D., & Drew R.C. (2018). Omega‐3 polyunsaturated fatty acid supplementation reduces blood pressure but not renal vasoconstrictor response to orthostatic stress in healthy older adults. Physiol Rep, 6(8), e13674.

DeFilippis, A.P. & L.S. Sperling. (2006). Understanding omega-3's. Am Heart J, 151(3), 564-570.

Emery, S., Häberling I., Berger G., Walitza S., Schmeck K., Albert T., Baumgartner N., Strumberger M., Albermann M., & Drechsler R. (2020). Omega-3 and its domain-specific effects on cognitive test performance in youths: A meta-analysis. Neurosci Biobehav Rev, 112, 420-436.

Farrell, J., Ries N.M., & Boon H. (2008). Pharmacists and natural health products: a systematic analysis of professional responsibilities in Canada. Pharm Pract (Granada), 6(1), 33-42.

Food and Drug Administration. Petition for a health claim for eicosapentaenoic acid and docosahexaenoic acid and reduction of blood pressure in the general population (docket no. FDA-2014-Q-1146). Available online: www.fda.gov/media/128043/download (accessed on 06 June 2025).

Freund-Levi, Y., Basun H., Cederholm T, Faxén-Irving G., Garlind A., Grut M., Vedin I., Palmblad J., Wahlund L-O., & Eriksdotter-Jönhagen M. (2008). Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms. Int J Geriatr Psychiatry, 23(2), 161-169.

Fu, Y.Q., Zheng J.S., Yang B., & Li D. (2015). Effect of individual omega-3 fatty acids on the risk of prostate cancer: a systematic review and dose-response meta-analysis of prospective cohort studies. J Epidemiol, 25(4), 261-274.

Gebauer, S.K., Psota T.L., Harris W.S., & Kris-Etherton P.M. (2006). N-3 fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits. Am J Clin Nutr, 83(6 Suppl), 1526S-1535S.

Grew, B., Schneider C.R., Mirzaei A., & Carter S.R. (2019). Validation of a questionnaire for consumers’ perception of service quality in community pharmacy. Res Social Adm Pharm, 15(6), 673-681.

Harris, W.S. (2010). Omega-3 Fatty Acids. In: Encyclopedia of dietary supplements (second ed). Edited by Coates P.M., Betz J.M., Blackman M.R., Cragg G.M., Levine M., Moss J. & White J.D. Informa Healthcare.

Health Canada. (2018). Natural Health Product. Fish Oil. September 2018.

Health Canada. (2024a). Natural Health Product. Fixed Oil Products – Oral. March 28, 2024. Available online: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multiple.oil&lang=eng (accessed on 06 June 2025).

Health Canada. (2024b). Natural Health Product. Fish Oil. March 28, 2024. Available online: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=fish.oil.huile.poisson&lang=eng (accessed on 06 June 2025).

Hooper, C., De Souto Barreto P., Coley N., Cantet C., Cesari M., Andrieu S., & Vellas B. (2017). Cognitive changes with omega-3 polyunsaturated fatty acids in non-demented older adults with low omega-3 index. J Nutr Health Aging, 21(9), 988-993.

Irving, G. F., Freund-Levi Y., Eriksdotter-Jönhagen M., Basun H., Brismar K., Hjorth E., Palmblad J., Vessby B., Vedin I., Wahlund L-O., & Cederholm T. (2009). Omega-3 fatty acid supplementation effects on weight and appetite in patients with Alzheimer's disease: the omega-3 Alzheimer's disease study. J Am Geriatr Soc, 57(1), 11-17.

Khan, S.U., Lonea A.N., Khanb M.S., Viranic S.S., Blumenthald R.S., Nasir K., Millerh M., Michos E.D., Ballantynec C.M., Bodeni W.E., & Bhatt D.L. (2021). Effect of omega-3 fatty acids on cardiovascular outcomes: a systematic review and meta-analysis. EClinicalMedicine, 38, 100997.

Kheir, N., Gad H.Y., & Abu-Yousef S.E. (2014). Pharmacists’ knowledge and attitudes about natural health products: a mixed-methods study. Drug Healthc Patient Saf, 6, 7-14.

Kwan, D., Hirschkorn K., & Boon H. (2006). U.S. and Canadian pharmacists’ attitudes, knowledge, and professional practice behaviors toward dietary supplements: a systematic review. BMC Complement Altern Med, 6, 1.

Lane, K., Derbyshire E., Li W., & Brennan C. (2014). Bioavailability and potential uses of vegetarian sources of omega-3 fatty acids: a review of the literature. Crit Rev Food Sci Nutr, 54(5), 572-579.

Mozaffarian, D. (2024). Fish oil: Physiological effects and administration. UpToDate. Available online: www.uptodate.com/contents/fish-oil-physiologic-effects-and-administration/print (accessed on 06 June 2025).

Phillips, M.A., Childs C.E., Calder P.C., & Rogers P.J. (2015). No effect of omega-3 fatty acid supplementation on cognition and mood in individuals with cognitive impairment and probable Alzheimer's disease: a randomised controlled trial. Int J Mol Sci, 16(10), 24600-24613.

Quinn, J.F., Raman R., Thomas R.G., Yurko-Mauro K., Nelson E.B., & Van Dyck C., Galvin J.E., Emond J., Jack Jr C.R., Weiner M., Shinto L., & Aisen P.S. (2010). Docosahexaenoic acid supplementation & cognitive decline in Alzheimer disease: a randomized trial. JAMA, 304(17), 1903-1911.

Sinn, N., Milte C.M., Street S.J., Buckley J.D., Coates A.M., Petkov J., & Howe P.R.C. (2012). Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial. Br J Nutr, 107(11), 1682-1693.

Spector, A.A. (1999). Essentiality of fatty acids. Lipids, 34 Suppl, S1-3.

US National Institutes of Health. (2024). Omega-3 fatty acids. fact sheet for health professionals. Available online: https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/ (accessed 06 June 2025).

Vakhapova, V., Cohen T., Richter Y., Herzog Y., & Korczyn A.D. (2010). Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in non-demented elderly with memory complaints: a double-blind placebo-controlled trial. Dement Geriatr Cogn Disord, 29(5), 467-474.

Venegas-Caleron M., Sayanova O., & Napier J.A. (2010). An alternative to fish oils: Metabolic engineering of oil-seed crops to produce omega-3 long chain polyunsaturated fatty acids. Prog Lipid Res, 49(2), 108-119.

Wei, B.Z., Li L., Dong C.W., Tan C.C., Alzheimer’s Disease Neuroimaging Initiative, & Xu W. (2023). The relationship of omega-3 fatty acids with dementia and cognitive decline: evidence from prospective cohort studies of supplementation, dietary intake, and blood markers. Am J Clin Nutr, 117(6), 1096-1109.

World Health Organization. (2022). World Mental Health Report. Transforming mental health for all. Available online: www.who.int/publications/i/item/9789240049338 (accessed on 06 June 2025).

Yang, C.P., Chang C.M., Yang C.C., Pariante C.M., & Su K.P. (2022). Long COVID and long chain fatty acids (LCFAs): psychoneuroimmunity implication of omega-3 LCFAs in delayed consequences of COVID-19. Brain Behav Immun, 103, 19-27.

Yurko-Mauro K., McCarthy D., Rom D., Nelson E.B., Ryan A.S., Blackwell A., Salem Jr N., Stedman M, & MIDAS Investigators. (2010). Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement, 6(6), 456-464.

Xie, R. & Zhang Y. (2023). Association between 19 Dietary fatty acids intake and rheumatoid arthritis: results of a nationwide survey. Prostaglandins Leukotrienes and Essential Fatty Acids, 188, 102530.